日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Connexin 36-mediated gap junctions contribute to fine odour discrimination and late-phase excitation of mitral cells in the mouse olfactory bulb

连接蛋白36介导的间隙连接有助于小鼠嗅球中精细气味的辨别和僧帽细胞的晚期兴奋。

Kuruppath, Praveen; Jones, Shelly T; Pouille, Frederic; Ramirez-Gordillo, Daniel; Restrepo, Diego; Schoppa, Nathan E

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

在美国,一项首次人体I期随机试验,旨在评估V2特异性HIV-1广谱中和抗体PGDM1400LS在未感染HIV-1的人群中静脉或皮下输注的安全性、药代动力学和中和活性(HVTN 140/HPTN 101 A部分):一项首次人体试验。

Seaton, Kelly E; Paez, Carmen A; Yu, Chenchen; Karuna, Shelly T; Gamble, Theresa; Miner, Maurine D; Heptinstall, Jack; Zhang, Lu; Gao, Fei; Yacovone, Margaret; Spiegel, Hans; Dumond, Julie B; Anderson, Maija; Piwowar-Manning, Estelle; Dye, Bonnie; Tindale, India; Proulx-Burns, Lori; Trahey, Meg; Takuva, Simbarashe; Takalani, Azwidihwi; Bailey, Veronique C; Kalams, Spyros A; Scott, Hyman; Mkhize, Nonhlanhla N; Weiner, Joshua A; Ackerman, Margaret E; McElrath, M Juliana; Pensiero, Michael; Barouch, Dan H; Montefiori, David; Tomaras, Georgia D; Corey, Lawrence; Cohen, Myron S; Huang, Yunda; Mahomed, Sharana; Siegel, Marc; Kelley, Colleen F

Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV

对一种广谱中和HIV的单克隆抗体VRC07-523LS进行药代动力学相互作用评估:一项纳入三项I期临床试验的非HIV感染者交叉方案分析

Chawana, Tariro D; Walsh, Stephen R; Stranix-Chibanda, Lynda; Chirenje, Zvavahera M; Yu, Chenchen; Zhang, Lily; Seaton, Kelly E; Heptinstall, Jack; Zhang, Lu; Paez, Carmen A; Gamble, Theresa; Karuna, Shelly T; Andrew, Philip; Hanscom, Brett; Sobieszczyk, Magdalena E; Edupuganti, Srilatha; Gay, Cynthia L; Mannheimer, Sharon B; Hurt, Christopher B; Stephenson, Kathryn E; Polakowski, Laura L; Spiegel, Hans; Yacovone, Margaret; Regenold, Stephanie; Yen, Catherine; Baumblatt, Jane Ag; Gama, Lucio; Barouch, Dan H; Piwowar-Manning, Estelle; Koup, Richard A; Tomaras, Georgia D; Hyrien, Ollivier; Roxby, Alison C; Huang, Yunda

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

广谱中和抗体VRC01对抗体介导预防试验中HIV突破性病毒群体的影响

Williamson, Carolyn; Moodley, Chivonne; Magaret, Craig A; Giorgi, Elena E; Rolland, Morgane; Westfall, Dylan H; Yssel, Anna; Deng, Wenjie; Rossenkhan, Raabya; Mkhize, Nonhlanhla N; Chen, Lennie; Zhao, Hong; Bhattacharya, Tanmoy; Pankow, Alec; Murrell, Ben; York, Talita; Gwashu-Nyangiwe, Asanda; Ndabambi, Nonkululeko; Thebus, Ruwayhida; Cohen, Paula; Lambson, Bronwen; Kaldine, Haajira; Bhebhe, Sinethemba; Juraska, Michal; Bai, Hongjun; deCamp, Allan C; Ludwig, James; Molitor, Cindy; Beaume, Nicolas; Matten, David; Huang, Yunda; Zhang, Lily; Reeves, Daniel B; Mayer, Bryan; Karuna, Shelly T; Hural, John A; Morris, Lynn; Montefiori, David; Bumgarner, Roger E; Moore, Penny L; Edlefsen, Paul T; Edupuganti, Srilatha; Mgodi, Nyaradzo; McElrath, M Juliana; Cohen, Myron S; Corey, Lawrence; Gilbert, Peter B; Mullins, James I

Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study

成人HIV-1预防性单克隆抗体固定剂量与按体重给药的比较:一项事后交叉方案药代动力学建模研究

Huang, Yunda; Zhang, Lily; Gelderblom, Huub; Seaton, Kelly E; Yates, Nicole L; Paez, Carmen A; Karuna, Shelly T; Andrew, Philip; Gamble, Theresa; Robinson, Samuel T; Ledgerwood, Julie E; Hyrien, Ollivier; Walsh, Stephen R; Gay, Cynthia L; Gwira, Jane A; Spiegel, Hans M L; Sobieszczyk, Magdalena E; Mannheimer, Sharon B; Edupuganti, Srilatha; Hurt, Christopher B; Stephenson, Kathryn E; Yu, Chenchen; Kelley, Colleen F; Mahomed, Sharana; Siegel, Marc; Yacovone, Margaret; Pensiero, Michael N; Donnell, Deborah; Cohen, Myron S; Corey, Lawrence; Gilbert, Peter B; Koup, Richard A; Tomaras, Georgia D

Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085

简报:HVTN 704/HPTN 085 研究中,被动输注 VRC01 或安慰剂后,性别与主动报告的不良事件之间的关联

Theodore, Deborah A; Neradilek, Moni; Gillespie, Kevin; Edupuganti, Srilatha; Hinojosa, Juan Carlos; Lama, Javier R; De La Grecca, Robert; Wu, Yi H; Davis, Annet; Mangini, Daniel; Andrew, Philip; Marovich, Mary A; Zwerski, Sheryl; Broder, Gail; Andrasik, Michele P; Castor, Delivette; Roxby, Alison C; Cohen, Myron; Huang, Yunda; Karuna, Shelly T; Sobieszczyk, Magdalena E

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

作者更正:在抗体介导预防试验中,高单克隆中和抗体滴度降低了突破性 HIV-1 病毒载量。

Reeves, Daniel B; Mayer, Bryan T; deCamp, Allan C; Huang, Yunda; Zhang, Bo; Carpp, Lindsay N; Magaret, Craig A; Juraska, Michal; Gilbert, Peter B; Montefiori, David C; Bar, Katharine J; Cardozo-Ojeda, E Fabian; Schiffer, Joshua T; Rossenkhan, Raabya; Edlefsen, Paul; Morris, Lynn; Mkhize, Nonhlanhla N; Williamson, Carolyn; Mullins, James I; Seaton, Kelly E; Tomaras, Georgia D; Andrew, Philip; Mgodi, Nyaradzo; Ledgerwood, Julie E; Cohen, Myron S; Corey, Lawrence; Naidoo, Logashvari; Orrell, Catherine; Goepfert, Paul A; Casapia, Martin; Sobieszczyk, Magdalena E; Karuna, Shelly T; Edupuganti, Srilatha

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

VRC07-523LS 不同给药途径和剂量(HVTN 127/HPTN 087)的安全性和药代动力学:一项 I 期随机临床试验

Walsh, Stephen R; Gay, Cynthia L; Karuna, Shelly T; Hyrien, Ollivier; Skalland, Timothy; Mayer, Kenneth H; Sobieszczyk, Magdalena E; Baden, Lindsey R; Goepfert, Paul A; Del Rio, Carlos; Pantaleo, Guiseppe; Andrew, Philip; Karg, Carissa; He, Zonglin; Lu, Huiyin; Paez, Carmen A; Baumblatt, Jane A G; Polakowski, Laura L; Chege, Wairimu; Anderson, Maija A; Janto, Sophie; Han, Xue; Huang, Yunda; Dumond, Julie; Ackerman, Margaret E; McDermott, Adrian B; Flach, Britta; Piwowar-Manning, Estelle; Seaton, Kelly; Tomaras, Georgia D; Montefiori, David C; Gama, Lucio; Mascola, John R

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

广谱中和抗体VRC01的预防效力取决于HIV-1包膜序列特征。

Juraska, Michal; Bai, Hongjun; deCamp, Allan C; Magaret, Craig A; Li, Li; Gillespie, Kevin; Carpp, Lindsay N; Giorgi, Elena E; Ludwig, James; Molitor, Cindy; Hudson, Aaron; Williamson, Brian D; Espy, Nicole; Simpkins, Brian; Rudnicki, Erika; Shao, Danica; Rossenkhan, Raabya; Edlefsen, Paul T; Westfall, Dylan H; Deng, Wenjie; Chen, Lennie; Zhao, Hong; Bhattacharya, Tanmoy; Pankow, Alec; Murrell, Ben; Yssel, Anna; Matten, David; York, Talita; Beaume, Nicolas; Gwashu-Nyangiwe, Asanda; Ndabambi, Nonkululeko; Thebus, Ruwayhida; Karuna, Shelly T; Morris, Lynn; Montefiori, David C; Hural, John A; Cohen, Myron S; Corey, Lawrence; Rolland, Morgane; Gilbert, Peter B; Williamson, Carolyn; Mullins, James I

Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials

HIV疫苗试验网络704/HIV预防试验网络085研究中口服暴露前预防药物的接受度和停药情况:对生物医学人类免疫缺陷病毒预防试验的启示

Cantos, Valeria D; Neradilek, Moni; Huang, Yunda; Roxby, Alison C; Gillespie, Kevin; deCamp, Allan C; Karuna, Shelly T; Edupuganti, Srilatha; Gallardo-Cartagena, Jorge; Sanchez, Jorge; Del Rio, Carlos; Veloso, Valdilea; Cohen, Myron S; Donnell, Deborah J; Corey, Lawrence; Kelley, Colleen F